Related Experiment Video

Updated: Jan 26, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K

Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy

Zackary D Goff1, Hugh Calkins2

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Progress in Cardiovascular Diseases
|April 21, 2019
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is an inherited heart condition. This review focuses on preventing sudden cardiac death (SCD) in HCM patients and compares guidelines for implantable cardioverter-defibrillator (ICD) use.

Area of Science:

  • Cardiology
  • Genetics
  • Preventive Medicine

Background:

  • Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition.
  • Most individuals with HCM have mild symptoms but face risks of ventricular arrhythmias and sudden cardiac death (SCD).
  • Implantable cardioverter-defibrillators (ICDs) have improved HCM prognosis, reducing mortality rates.

Purpose of the Study:

  • To review key concepts of hypertrophic cardiomyopathy (HCM).
  • To emphasize strategies for preventing sudden cardiac death (SCD) in HCM patients.
  • To summarize and compare current guideline recommendations for ICD implantation in HCM.

Main Methods:

  • Literature review of hypertrophic cardiomyopathy (HCM).
  • Analysis of sudden cardiac death (SCD) risk stratification models.
  • Comparative review of current international guidelines for ICD implantation.

Main Results:

  • HCM is a genetic disorder with variable symptoms.
  • SCD remains a significant risk, necessitating risk stratification.
  • Guidelines for ICD implantation in HCM have evolved to balance prevention and necessity.

Conclusions:

  • HCM management requires careful consideration of SCD risk.
  • ICD implantation is crucial for preventing SCD in high-risk HCM patients.
  • Ongoing evaluation of risk stratification models and guidelines is essential for optimal HCM care.

Keywords:
CardiomyopathyHypertrophic cardiomyopathySudden cardiac death

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.4K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
454
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
519
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
498
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
374
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
552
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
333